2024 |
Bicycle Therapeutics Plc - ADR
|
Director and Chief Executive Officer |
- |
- |
2023 |
Bicycle Therapeutics Plc - ADR
|
Director and Chief Executive Officer |
5.5 M |
-35.8 % |
2022 |
Bicycle Therapeutics Plc - ADR
|
Director and Chief Executive Officer |
8.6 M |
93.2 % |
2021 |
Bicycle Therapeutics Plc - ADR
|
- |
4.5 M |
78.1 % |
2021 |
Bicycle Therapeutics Plc - ADR
|
Director; Chief Executive Officer of Company and BicycleTx |
4.5 M |
78.1 % |
2020 |
Bicycle Therapeutics Plc - ADR
|
- |
2.5 M |
-42.7 % |
2020 |
Bicycle Therapeutics Plc - ADR
|
- |
2.5 M |
-42.7 % |
2020 |
Bicycle Therapeutics Plc - ADR
|
Director; Chief Executive Officer of Company and BicycleTx |
2.5 M |
-42.7 % |
2019 |
Bicycle Therapeutics Plc - ADR
|
- |
4.4 M |
435.1 % |
2019 |
Bicycle Therapeutics Plc - ADR
|
- |
4.4 M |
435.1 % |
2019 |
Bicycle Therapeutics Plc - ADR
|
Director; Chief Executive Officer of Company and BicycleTx |
4.4 M |
435.1 % |
2018 |
Bicycle Therapeutics Plc - ADR
|
- |
817.9 K |
- |
2018 |
Bicycle Therapeutics Plc - ADR
|
- |
817.9 K |
- |
2018 |
Bicycle Therapeutics Plc - ADR
|
Chief Executive Officer and Director |
817.9 K |
- |